Dividends & Buybacks ·
Neuraxis, Inc. declared a stock dividend for the second quarter of 2026 on its Series B Preferred Stock, which will be…
NRXSNeuraxis, Inc
Neuraxis, Inc. declared a stock dividend for the second quarter of 2026 on its Series B Preferred Stock, which will be stock in the form of common stock. Approximately 80,463 shares of common stock are expected to be issued, with fractional shares being settled in cash. The dividend is payable on July 29, 2026, to holders of record as of July 21, 2026, based on a conversion factor of conversion factor of $2.38 per share. Neuraxis, Inc. operates in the biotechnology/medical technology sector.